Sanofi
Holly, wearing a blue blouse, sits in an armchair in a living room setting with her provider, Dr. Michael Tarantino, wearing glasses, a grey suit, and a purple tie, during a conversation about ITP.

Voices in ITP Care: The Power of Shared Decision-Making

Holly shares her journey with immune thrombocytopenia (ITP), from persistent fatigue to diagnosis, and how partnering with her doctor helped her advocate for care that supports her whole life—not just her platelet count.

Headshots of Elizabeth Franklin, Head of US Public Affairs and Patient Advocacy, Oncology and Tom Snow, General Manager of US Oncology

Beyond the Science: Understanding the Patient Journey to Shape the Future of Myeloma Care

Tom Snow, General Manager of US Oncology and Elizabeth Franklin, Head of US Public Affairs and Patient Advocacy, Oncology share how Sanofi’s patient-centric approach aims to address unmet needs and ease the burden on people living with multiple myeloma.

READ MORE
Headshots of the three Sanofi Healthcare Businesswomen’s Association Luminaries and Rising Stars – Asma Ali, Daye Bexley, and Rachel Solomon

Honoring Sanofi’s 2025 Healthcare Businesswomen’s Association (HBA) Luminaries and Rising Stars

Learn more about Sanofi’s HBA Luminaries and Rising Stars – Asma Ali, Daye Bexley, and Rachel Solomon – who each chase the miracles of science to improve the lives for so many people in the communities they help represent at work and beyond.

READ MORE

Latest News

July 30, 2025
Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma
READ MORE
June 22, 2025
BEYFORTUS® reduced hospital and doctor visits for RSV disease in babies by 87%, according to largest US real-world study
READ MORE
June 26, 2025
Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts
READ MORE

Explore More

Nadège Bailleul inspects a set of 12 small clear vials on a steel rack next to a fume hood in a darkened room.

Second Quarter 2025 Results

July 31, 2025

Second quarter 2025 results were reviewed by management during a live audio webcast with the financial community.

DISCOVER MORE

Sanofi’s 2025 Pricing Principles Report

Sanofi’s 2025 Pricing Principles Report underscores our commitment to fostering a culture of transparency in the healthcare system and advocating for policies that make our treatments accessible and affordable to those in need.

READ MORE

A Million Conversations

People need healthcare systems – at all levels – to better reflect society. So we must listen to marginalized communities more and use those insights to help the healthcare industry, policymakers and governments to fix the causes of these trust gaps.

READ MORE

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Explore Career Opportunities

MAT-US-2014105-v8.0-01/2024